Merck & Co., Inc. CEDEAR (MRK)
Market Closed
17 Dec, 20:00
BCBA BCBA Primary BCBA AR$
30,740. 00
+480
+1.59%
AR$
- Market Cap
58.39 P/E Ratio
3.08% Div Yield
1,086 Volume
1.46 Eps
AR$ 30,260
Previous Close Day Range
30,280 30,960
Year Range
16,950 32,380
Want to track MRK and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 47 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| MRK Merck & Co., Inc. CEDEAR 3 Feb 2026 (In 1 month) | | - | - |
| MRK Merck & Co., Inc. CEDEAR 30 Oct 2025 | | - | - |
| MRK Merck & Co., Inc. CEDEAR 29 Jul 2025 | | - | - |
| MRK Merck & Co., Inc. CEDEAR 24 Apr 2025 | | - | - |
MRK Earnings Reports FAQ
What is the earnings per share (EPS) for MRK?
The current EPS is 1.46.
What is the company's earnings growth rate?
Merck & Co., Inc. CEDEAR has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-03, based on the MRK's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Merck & Co., Inc. CEDEAR are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for MRK at this time, as Merck & Co., Inc. CEDEAR has no recent EPS data to calculate it.
